Daily News Podcast

Concerns over CMS E/M payment proposal


 

The CMS says that the need to reduce time spent coding is driving its new proposal to flatten the 2019 payment for E&M visits that are coded levels 2-5. Also today, low disease activity in SLE compares favorably with clinical remission, medical associations want withdrawal of Title X changes, and telomere length is linked to COPD exacerbations and mortality. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

CTCs linked to late recurrence in HER2–, HR+ breast cancer
MDedge Hematology and Oncology
Free skin cancer screening highlights need
MDedge Hematology and Oncology
Valsartan cancer risk is low
MDedge Hematology and Oncology
Finally, new migraine drugs
MDedge Hematology and Oncology
Changes to doctor payment for in-office drugs
MDedge Hematology and Oncology
E-cigarettes: Prices down, sales up
MDedge Hematology and Oncology
No meaningful decline in opioid use
MDedge Hematology and Oncology
FDA warns against azithromycin in blood or lymph node cancers
MDedge Hematology and Oncology
Fibrosis progression linked to weight
MDedge Hematology and Oncology
FDA warns about azithromycin in some cancers
MDedge Hematology and Oncology